Iwaki & Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Iwaki & Co., Ltd. with three other
companies in this sector in Japan:
Katakura Industries Co Ltd
sales of 48.57 billion Japanese Yen [US$468.73 million]
of which 31%
was Pharmaceutical Products),
Zeria Pharmaceutical Co Ltd
(61.01 billion Japanese Yen [US$588.77 million]
of which 55%
was Pharmaceuticals Business), and
CMIC Holdings Co Ltd
(55.90 billion Japanese Yen [US$539.47 million]
of which 49%
was Cro Business).
Iwaki & Co., Ltd. reported sales of ¥55.42 billion (US$534.83 million)
November of 2015.
increase of 2.4%
versus 2014, when the company's sales were ¥54.15 billion.
This was the third consecutive year of growth at Iwaki & Co., Ltd..
The sales level in 2015 was fairly close to the level five years ago: in 2010, Iwaki & Co., Ltd. had sales
of ¥50.41 billion.